Your browser doesn't support javascript.
loading
Inclisiran and cardiovascular events: a patient-level analysis of phase III trials.
Ray, Kausik K; Raal, Frederick J; Kallend, David G; Jaros, Mark J; Koenig, Wolfgang; Leiter, Lawrence A; Landmesser, Ulf; Schwartz, Gregory G; Lawrence, David; Friedman, Andrew; Garcia Conde, Lorena; Wright, R Scott.
Afiliação
  • Ray KK; Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College, London, UK.
  • Raal FJ; Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Kallend DG; DalCor Pharmaceuticals, Montreal, Quebec, Canada.
  • Jaros MJ; LIB Therapeutics, Cincinnati, OH, USA.
  • Koenig W; Summit Analytical, Denver, CO, USA.
  • Leiter LA; German Heart Centre, Technical University Munich, DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
  • Landmesser U; Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.
  • Schwartz GG; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Canada.
  • Lawrence D; Department of Cardiology, Charité-University Medicine Berlin, Berlin Institute of Health (BIH), DZHK, Partner Site, Berlin, Germany.
  • Friedman A; Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Garcia Conde L; Novartis Pharma AG, Basel, Switzerland.
  • Wright RS; Population Health Partners, Short Hills, NJ, USA.
Eur Heart J ; 44(2): 129-138, 2023 01 07.
Article em En | MEDLINE | ID: mdl-36331326

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Anticolesterolemiantes Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Eur Heart J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Anticolesterolemiantes Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Eur Heart J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido